Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer

Lu Yang(Shanghai Jiao Tong University), Yuesheng Zhang(First Affiliated Hospital Zhejiang University)
Journal of Experimental & Clinical Cancer Research
June 1, 2022
Cited by 29


Related Papers